Our Expert in Panama
Search intent: Compliance and transactional, this guide answers whether a Panama merger filing is required, how to run the thresholds test, what documents and timeline to expect, and the consequences of closing without clearance.
Merger control Panama is one of the first regulatory questions deal teams must resolve before signing or closing a transaction that touches the Panamanian market. Whether a combination requires a filing, how thresholds are tested, how long clearance takes and what happens if parties close prematurely are the practical issues that determine deal timing and risk allocation. In 2026, heightened deal activity and refreshed regional rankings have pushed jurisdictional filing triggers and gun-jumping exposure to the top of the in-house counsel agenda. This pillar guide sets out the legal framework, the thresholds test, a filing checklist, realistic timelines and the penalties for non-compliance, all structured so that transaction teams can make a clear yes/no filing decision.
Read it alongside our M&A Process Panama, step-by-step guide for the wider transactional workflow.
TL;DR checklist:
Panama does not operate a universal mandatory suspensory pre-merger regime in the way some jurisdictions do; instead, its competition law provides for a voluntary pre-concentration verification before the authority, while preserving the authority’s power to investigate and challenge concentrations that harm competition. Panama’s competition regime is administered by its consumer-protection and competition authority. Parties to an economic concentration may seek advance verification to obtain legal certainty, and where a concentration would substantially lessen competition the authority may act, including after closing, to require remedies or to seek to unwind the transaction through the courts.
Because the availability and effect of verification, and any applicable market tests, are set by statute and implementing regulation, the safest course is to run a structured analysis early and confirm the current position with the regulator before assuming a deal raises no issues.
For cross-border acquirers unfamiliar with Panamanian practice, the working assumption should be to screen every transaction with a Panamanian nexus for merger control panama exposure, and to consider seeking voluntary verification where a concentration produces meaningful overlaps in the Panamanian market. Early screening avoids the far more expensive problem of a post-closing challenge to a completed transaction.
Panama’s merger control regime sits within its broader competition law, which prohibits anti-competitive practices and establishes a review mechanism for economic concentrations. The concept of a “concentration” typically covers mergers, acquisitions of control, asset acquisitions that transfer a business, and the creation of full-function joint ventures, in short, any transaction that durably changes the structure of control over an economic activity in the Panamanian market. The statute defines both what constitutes a concentration and how the authority may review it, including through voluntary pre-concentration verification and post-closing investigation.
The regulator responsible for competition and consumer protection is the Autoridad de Protección al Consumidor y Defensa de la Competencia (ACODECO), which administers the competition mandate and provides procedural guidance for verifications. ACODECO’s role includes assessing whether a concentration would substantially lessen competition, requesting information from the parties, and, where necessary, seeking conditions or challenging a transaction, including before the specialised courts. Deal teams should treat ACODECO as the primary reference point for procedural rules, forms and contact details, and should verify the current mandate and any sectoral allocations of jurisdiction before proceeding.
Scope matters. Certain sectors in Panama are regulated by specialist authorities, and the interaction between sector regulators and the general competition authority can affect where and how a transaction is reviewed. Where a deal touches a regulated sector, for example, banking (Superintendencia de Bancos), telecommunications and utilities (ASEP), or insurance (Superintendencia de Seguros y Reaseguros), the parties should confirm whether the general competition regime, a sectoral clearance, or both apply. Getting this allocation right at the outset avoids duplicated or missed approvals.
Two official sources anchor any Panamanian merger control analysis. The first is ACODECO’s official site, which carries procedural rules, guidance and contact details for the competition division. The second is the Gaceta Oficial de la República de Panamá, the Official Gazette, which is the authoritative source for the competition statute, its implementing regulations and any amendments that change procedures. Because procedures and any relevant criteria can be adjusted by regulation, always cross-check the ACODECO guidance against the latest Gazette publications rather than relying on secondary summaries. For comparative best practice on completeness phases and remedies, the OECD, ICN and UNCTAD materials cited below provide useful context, though they do not substitute for the Panamanian primary sources.
The concentration analysis is the heart of any merger control panama assessment, because it determines whether a transaction carries competitive risk and whether voluntary verification is advisable. Panama’s regime is built around a definition of a concentration combined with an assessment of competitive effect. In practice, the analysis proceeds in a defined sequence, and each step should be documented so that the parties can demonstrate, to their own boards and, if needed, to the regulator, how they reached their conclusion.
Begin with the transaction structure. Ask whether the deal produces a lasting change of control or combines previously independent businesses. If it does, it is a candidate for review and should be run through the competitive analysis. If it does not, for example, a purely internal reorganisation within an already-controlled group, it may fall outside the concentration concept entirely, though this should be confirmed rather than assumed.
Next, gather the relevant financial and market metrics. You will typically need each party’s Panamanian turnover, group-level turnover attributable to the Panamanian market, and an estimate of the combined share in the affected product and geographic markets. Where the statute or regulation expresses any numeric criterion, that figure is authoritative and must be taken from the current regulation; any illustrative number used in planning should be treated as provisional and confirmed against the Gazette text before a final decision is made.
Then assess competitive effect. A worked approach is as follows. Where the parties have overlapping activities in a Panamanian market and the concentration would materially increase concentration or create or strengthen market power, the transaction carries competitive risk and voluntary verification should be seriously considered. Where the overlap is negligible and the market remains competitive, the risk of a post-closing challenge is correspondingly lower. Because these judgments turn on statutory criteria and the authority’s practice, they should be verified with the regulator rather than assumed.
Finally, document the outcome. Whether the answer is “seek verification” or “proceed without”, record the metrics used, the sources relied on, and the reasoning. This contemporaneous file is valuable if the transaction is later questioned, and it demonstrates good-faith compliance, a factor that can matter if any procedural issue arises. Running this analysis carefully at the term-sheet stage, rather than at signing, gives the deal team room to build any verification into the timetable.
Structure changes the analysis. A share deal that transfers control of a Panamanian target is a classic concentration and will be assessed on the parties’ combined metrics. An asset deal can amount to a concentration where the assets constitute a business or a self-standing revenue-generating operation, because the acquisition transfers market presence even without a share transfer; a purchase of isolated assets that do not amount to a business is less likely to be caught.
A joint venture raises its own questions: a full-function JV that operates on a lasting basis as an autonomous economic entity is generally treated as a concentration, whereas a purely contractual or short-lived cooperative arrangement may fall outside the concentration definition and instead be assessed under the conduct rules. When in doubt, characterise the transaction by its economic substance rather than its label.
Not every combination raises competition concern, and some sectors are handled differently. Intra-group reorganisations that do not change ultimate control, and transactions with no appreciable effect on the Panamanian market, will generally not warrant review. Where a specialist sector regulator holds a merger or ownership-approval mandate, the deal may require a sectoral clearance in addition to, or instead of, engagement with the general competition authority. Because the boundaries are defined by statute and regulation and can be narrow, treat any assumption that a deal is outside the regime as something to be confirmed with the regulator rather than presumed.
Where the analysis confirms that a verification before ACODECO is appropriate, the objective is to submit a complete request that the authority can accept and begin reviewing without repeated requests for missing information. Completeness is the single most important driver of a fast outcome, because the substantive review generally proceeds once the authority has the information it needs. A well-prepared concentration filing in Panama, assembled before signing where possible, protects the closing timetable.
A typical documentation package includes the following:
Filings should be prepared in Spanish, with translations of key foreign-language documents where required. Confidentiality is a live issue: parties will usually request confidential treatment of commercially sensitive information, such as detailed turnover data, customer lists and internal strategy documents, and should identify the confidential material clearly and provide a non-confidential version where the regime requires one. Check the current position on any applicable cost with the regulator and confirm the accepted format for submission before lodging.
The competitive assessment is where a filing either reassures or alarms the regulator. Keep it disciplined. Define the relevant product and geographic markets by reference to demand-side substitutability, then identify any horizontal overlaps between the parties and quantify the combined position with realistic share estimates. Address vertical relationships where one party supplies an input the other uses, since these can raise foreclosure concerns. Where overlaps are modest and the market remains competitive with credible alternative suppliers, say so plainly and support it with evidence. A candid, well-evidenced assessment that anticipates the regulator’s questions shortens the review and reduces the likelihood of an in-depth investigation.
For multi-jurisdictional transactions, coordinate the Panamanian engagement with parallel foreign filings so that closing conditions align. Build a timetable that identifies the longest-pole jurisdiction, prepare a consistent narrative across all filings to avoid contradictory positions, and include a short local competition memo in the Panamanian package explaining the transaction’s effect on the domestic market. Where simultaneous closing across jurisdictions is commercially important, sequence the process so that any Panamanian review is not the item that holds up global completion.
Understanding the review timeline in Panama is essential for setting closing dates and drafting conditions precedent. Review generally proceeds through distinct phases. The first is an acceptance or completeness phase, in which the authority checks that the request contains the required information; if material is missing, the parties are asked to supply it, and the substantive review typically does not begin, or is paused, until the file is complete. The second is the substantive review phase, in which the regulator assesses whether the concentration would substantially lessen competition. Where concerns arise, the process can move into a remedies phase, during which the parties negotiate structural or behavioural undertakings to address the identified harm.
Practical durations vary with complexity. Straightforward transactions with no meaningful overlap tend to conclude at the shorter end of the range once the file is accepted as complete. Deals with genuine competitive overlaps, or those requiring market testing of proposed remedies, take longer and may extend into an in-depth phase. Any specific procedural period should be confirmed against the current regulation, because these deadlines are set by rule and can change; the illustrative distinction to plan around is fast-track for uncontroversial cases, standard for typical matters, and extended for cases involving remedies or in-depth scrutiny.
Be alert to “stop-the-clock” mechanics. Where the regulator issues a formal request for information, the review period can be suspended until the parties respond, so incomplete or slow responses directly delay the outcome. The practical lesson is that the parties control much of their own timetable: a complete, well-organised submission and prompt, comprehensive responses to information requests are the most reliable ways to keep the merger review timeline Panama on track.
Requests for information are routine in anything but the simplest cases, and how the parties handle them shapes both timing and outcome. Respond fully and quickly, provide the data in the format requested, and use the opportunity to reinforce the pro-competitive narrative. If the regulator signals concerns, engage early on remedies rather than waiting for a formal position. Structural remedies, such as divesting an overlapping business, tend to be favoured where they cleanly remove the competitive concern, while behavioural undertakings may suit vertical or access issues. Proposing credible, well-defined remedies proactively can convert a potential objection into a conditional resolution and shorten the overall process.
The most serious compliance risk in any merger control panama analysis is implementing a concentration that harms competition without engaging the authority, and then facing a post-closing investigation. Where a concentration substantially lessens competition, ACODECO can investigate, seek remedies and, through the specialised competition courts, pursue orders that unwind or restructure the transaction. Administrative sanctions and remedy orders may follow. Where a concentration has already harmed competition, the authority may pursue divestitures or other structural remedies to restore competitive conditions, and behavioural undertakings may be sought to constrain the merged entity’s conduct.
Beyond the administrative consequences, a challenged concentration carries commercial and reputational costs. A forced divestiture destroys deal value, an unwinding order creates operational chaos, and public enforcement action damages the parties’ standing with regulators in other jurisdictions. Contractually, the crystallisation of regulatory risk can trigger indemnity claims, termination rights or price adjustments between buyer and seller, depending on how the agreement allocates that risk. These downstream effects make competition risk a board-level priority, not merely a legal formality.
The protective measures are well established. Consider seeking voluntary verification where competitive overlaps are material, so as to obtain legal certainty before closing. Where verification is pursued, keep the businesses separate through hold-separate arrangements and interim covenants that preserve the target’s independence and prevent premature integration. Limit information exchange to what is necessary and use clean-team protocols for competitively sensitive data. Where regulatory risk is material, allocate it explicitly in the agreement, through escrow, break-fee mechanics, or warranty and indemnity insurance, so that both sides understand who bears the cost if a concern is raised. Together, these measures let the parties progress the transaction while managing competition exposure.
If the parties realise that a completed concentration may harm competition, act immediately and deliberately. First, halt any further integration and reinstate hold-separate measures to limit the competitive effect. Second, take legal advice on a prompt, candid approach to the regulator: voluntary engagement and cooperation can mitigate exposure and demonstrate good faith. Third, prepare a full information package so that the authority can conduct a proper assessment. Fourth, document the timeline and the corrective steps taken. Proactive cooperation does not guarantee a favourable outcome, but a transparent response is materially better than waiting for the regulator to discover the concern.
| Feature | Panama (this guide) | Typical mandatory-notification LA model |
|---|---|---|
| Filing required? | Voluntary pre-concentration verification, with post-closing review powers | Often mandatory pre-merger notification |
| Assessment basis | Concentration definition and competitive-effects test (see statute) | Often turnover-based or market-share thresholds |
| Typical review timeline | Short-to-medium (see timeline section) | Varies; often longer with second-phase investigations |
| Common remedies | Divestiture, behavioural undertakings, unwinding via the courts | Similar |
The snapshot shows that Panama’s framework differs from the mandatory-notification model prevalent elsewhere in the region: rather than a universal suspensory filing obligation, Panama offers voluntary verification for legal certainty, backed by the authority’s power to review and challenge concentrations after the fact. The practical differences lie in the voluntary nature of verification, the length of any procedural clocks and the intensity of in-depth review, all of which should be confirmed against current Panamanian regulation rather than assumed from regional norms. For cross-border acquirers, the takeaway is that Panama’s regime must be verified locally rather than treated as identical to neighbouring mandatory-filing systems.
Merger control Panama should be assessed at the earliest possible stage of any transaction with a Panamanian nexus, because the competitive analysis determines whether to seek verification and how much time to build into the timetable. The general regime is centred on voluntary pre-concentration verification, administered by ACODECO, and backed by the authority’s power to investigate and challenge concentrations, in the worst case, through court orders that unwind a completed deal. The practical priorities are clear: run the analysis early, assemble a complete package, respond promptly during review, keep the businesses separate until any verification concludes, and confirm whether sectoral approvals apply. For a transaction-specific assessment, deal teams should seek qualified Panamanian advice.
Read our M&A Lawyer Fees Panama, 2026 fee ranges and M&A Process Panama, step-by-step guides for the wider deal context, and see the Panama M&A specialist profile for further reading.
This article was produced by Global Law Experts. For specialist advice on this topic, contact Mario Alberto Arias V. at ARIAS ABREGO LOPEZ & NORIEGA, a member of the Global Law Experts network.
posted 14 minutes ago
posted 36 minutes ago
posted 1 hour ago
posted 1 hour ago
posted 1 hour ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 2 hours ago
posted 3 hours ago
posted 3 hours ago
posted 3 hours ago
Find the right Legal Expert for your business
Send welcome message